TITLE

Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials

AUTHOR(S)
Hood, Sheila C.; Moher, David; Barber, Graeme G.
PUB. DATE
October 1996
SOURCE
CMAJ: Canadian Medical Association Journal;10/15/1996, Vol. 155 Issue 8, p1053
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35493998

 

Related Articles

  • Effects of Pentoxifylline on Severe Intermittent Claudication. Reich, Theobald; Gilings, Dennis // Angiology;Sep1987, Vol. 38 Issue 9, p651 

    Pentoxifylline has been shown to improve treadmill walking distances under blinded, controlled conditions in patients with intermittent claudication. From the pooled data of a blinded, controlled, randomized, multicenter trial, the data from all enrolled patients with severe claudication (< 70 m...

  • A randomized trial of iloprost in patients with intermittent claudication. Creager, Mark A.; Pande, Reena L.; Hiatt, William R. // Vascular Medicine;2008, Vol. 13 Issue 1, p5 

    Prostanoids, which promote vasodilation and reduce platelet aggregation, have been proposed as candidate therapies for intermittent claudication due to peripheral arterial disease (PAD). However, studies of these medications have yielded inconsistent results. This study tested the hypothesis...

  • Treatment of Intermittent Claudication with Pentoxifylline: A 12-Month, Randomized Trial. De Sanctis, M.T.; Cesarone, M.R.; Belcaro, G.; Nicolaides, A.N.; Griffin, M.; Incandela, L.; Bucci, M.; Geroulakos, G.; Ramaswami, G.; Vasdekis, S.; Agus, G.; Bavera, P.; Ippolito, E. // Angiology;Jan/Feb2002 Supplement, Vol. 53, pS7 

    Examines intermittent claudification in a double blind, randomized placebo control trial. Therapeutic use of pentoxifylline in the treatment; Efficacy and cost of pentoxifylline; Use of Doppler flowmetry to detect plaques, stenosis and flow alterations.

  • Cilastazol Improves Symptoms of Intermittent Claudication. Sadovsky, Richard // American Family Physician;5/15/2003, Vol. 67 Issue 10, p2214 

    Discusses the study 'Meta-Analysis of Results From Eight, Randomized, Placebo-Controlled Trials on the Effect of Cilostazol on Patients With Intermittent Claudication,' by P. D. Thompson et al., from the December 15, 2002 issue of the 'American Journal of Cardiology.'

  • Pentoxifylline for Intermittent Claudication. Ernst, E. // Angiology;May1994, Vol. 45 Issue 5, p339 

    Pentoxifylline was first introduced in Germany twenty years ago. Today it is the best researched oral drug for intermittent claudication. A total of seventeen placebo-controlled trials could be retrieved from the world literature. The majority of these studies show that pentoxifylline will...

  • Effective Therapies for Intermittent Claudication. RUDISILL, HEATHER M.; KELSBERG, GARY; SAFRANEK, SARAH // American Family Physician;9/15/2011, Vol. 84 Issue 6, p702 

    The article discusses effective therapies for the treatment of intermittent claudication. These include supervised exercise programs as to Strength of Recommendation (SOR: A) based on results of randomized controlled trials (RCTs) that were systematically reviewed and statins, antiplatelet...

  • Treatment of Long-Distance Intermittent Claudication with Pentoxifylline: A 12-Month, Randomized Trial. De Sanctis, M.T.; Cesarone, M.R.; Belcaro, G.; Nicolaides, A.N.; Griffin, M.; Incandela, L.; Bucci, M.; Geroulakos, G.; Ramaswami, G.; Vasdekis, S.; Agus, G.; Bavera, P.; Ippolito, E. // Angiology;Jan/Feb2002 Supplement, Vol. 53, pS13 

    Examines patients with intermittent claudification in a double-blind, randomized, placebo-controlled trial. Therapeutic use of pentoxifylline (PXF) in the treatment of intermittent claudification; Effectiveness of PXF; Administration of a standardized treadmill test to patients.

  • Intermittent Claudication in Diabetics: Treatment with Exercise and Pentoxifylline. Belcaro, G.; Nicolaides, A.N.; Griffin, M.; De Sanctis, M.T.; Cesarone, M.R.; Incandela, L.; Ippolito, E.; Pomante, P.; Geroulakos, G.; Ramaswami, G. // Angiology;Jan/Feb2002 Supplement, Vol. 53, pS39 

    Examines intermittent claudification in a double-blind, randomized, placebo-controlled trial. Treatment of diabetic patients with intermittent claudification with pentoxifylline (PXF); Criteria for including patients in the randomized trial; Efficacy and tolerability of PXF in the treatment of...

  • Treatment of Severe Intermittent Claudication with Pentoxifylline: A 40-Week, Controlled, Randomized Trial. Cesarone, M.R.; Belcaro, G.; Nicolaides, A.N.; Griffin, M.; De Sanctis, M.T.; Incandela, L.; Geroulakos, G.; Ramaswami, G.; Cazaubon, M.; Barsotti, A.; Vasdekis, S.; Bavera, P.; Ippolito, E. // Angiology;Jan/Feb2002 Supplement, Vol. 53, pS1 

    Examines the therapeutic use pentoxifylline in the treatment of severe intermittent claudication. Efficacy and safety of pentoxifylline; Comparison on the effectiveness of pentoxifylline and placebo; Presence of intermittent claudication in patient with vascular disease.

  • Sort-Range Intermittent Claudication and Rest Pain: Microcirculatory Effects of Pentoxifylline in a Randomized, Controlled Trial. Incandela, L.; De Sanctis, M.T.; Cesarone, M.R.; Belcaro, G.; Nicolaides, A.N.; Geroulakos, G.; Ramaswami, G. // Angiology;Jan/Feb2002 Supplement, Vol. 53, pS27 

    Examines patients with intermittent claudification in a double-blind, randomized, placebo-controlled trial. Efficacy of pentoxifylline (PXF) in severe intermittent claudification; Criteria for including patients in the trial; Conclusion that a high-dose of PXF improved the microcirculatory...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics